Review of BRICS regulatory practices in the field of drugs compounding

Review of BRICS regulatory practices in the field of drugs compounding

In the formation of a common market within the framework of interstate associations (Unions), the goal of improving the health of the member states population can be achieved, among other things, by providing an unimpeded access to safe, effective and quality medicines (drugs). One of the elements i...

Full description

Saved in:
Bibliographic Details
Main Authors: D. S. Yurochkin, D. D. Mamedov, S. E. Erdni-Garyaev, A. V. Yarutkin, V. L. Bagirova, P. S. Guryanov, O. Loudiyi, W. Li
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2024-11-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
legislation
brics
manufacturing of pharmaceuticals
diluting (reconstitution) of pharmaceuticals
compounding pharmacies
compounded medicinal products
quality of pharmaceuticals
regulatory practice
personalized medicine
brazil
india
china
republic of south africa
united arab emirates
iran
egypt
ethiopia
Online Access:https://www.pharmpharm.ru/jour/article/view/1548
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pharmpharm.ru/jour/article/view/1548

Similar Items